Global Artificial Womb Facility Market

Table of Content

1. Introduction

• Definition of Artificial Womb Facility Market

• Scope of the Report

2. Methodology

• Executive Summary

• Market Overview

• Market Definition and Segmentation

3. Market Dynamics

• Drivers

• Restraints

• Opportunities

• Porter's Five Forces Analysis

• PESTEL Analysis

4. Artificial Womb Facility Market, By Facility:

• Bioreactors

• Extrauterine Support Devices

• Other

5. Artificial Womb Facility Market, By Technology:

• Neonatal Intensive Care Units (NICUS)

• Birthing Centres

• Others

6. Artificial Womb Facility Market, By Application:

• Prenatal Care

• Neonatal Care

7. Artificial Womb Facility Market, By End-User:

• Hospitals

• Newborn Care Centres

• Others

8. Artificial Womb Facility Market, By Geography

• North America

  • United States

  • Canada

• Europe

  • United Kingdom

  • Germany

  • France

  • Spain

  • Italy

  • Rest of Europe

• Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Rest of Asia-Pacific

• Latin America

  • Brazil

  • Mexico

  • Rest of Latin America

• Middle East & Africa

  • Saudi Arabia

  • United Arab Emirates

  • South Africa

  • Rest of Middle East & Africa

9. Competitive Landscape

10. Company Profiles

• The Children's Hospital of Philadelphia (USA)

  • Company Overview

  • Product Portfolio and Description

  • Key Highlights

  • Financial Overview

• Womb Institute (USA)

• Preterm Birth Initiative (USA)

• Emmaus Life Sciences (USA)

• Virtus Health (USA)

• Institut für Labortechnik (Germany)

• Biotex (UK)

• TissUse GmbH (Germany)

• University of Zurich (Switzerland)

• Utrecht University (Netherlands)

• Juntendo University (Japan)

• Tokyo Women's Medical University (Japan)

• Shanghai First Maternity and Infant Hospital (China)

• Zhejiang University (China)

• National University of Singapore (Singapore)

• Universidad de los Andes (Colombia)

• Universidad de la República (Uruguay)

• Universidade Federal de São Paulo (Brazil)

• Universidad Nacional de Córdoba (Argentina)

• Universidad de Guadalajara (Mexico)

• King Abdullah University of Science and Technology (Saudi Arabia)

11. Conclusion and Future Outlook

12. Appendix

• Research Methodology

• About the Pharmanucleus

13. Disclaimer